Danazol for Evan's Syndrome Due to SLE

Pedro Aranegui, Pilar Giner, M López-Gómez, A. El Amrani, J Jiménez-Alonso
In: DICP · 1990 · vol. 24(6) , pp. 641–642 · doi:10.1177/106002809002400619 · PMID:2360344 · W2467925909
letter OA: closed CC0
Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".
View at publisher → View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-08 ⓘ

This case report describes the successful use of danazol to manage Evan's syndrome, a rare autoimmune disorder, in a patient with systemic lupus erythematosus (SLE).

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (2)

References (5)

Source provenance

openalex
last seen: 2026-05-11T03:53:21.355747+00:00
License: CC0 · commercial use OK